One Type of Older Diabetes Drug Cuts Dementia Risk, Another Ups It
Thiazolidinediones (TZDs), such as pioglitazone, appear to be protective against dementia whereas sulfonylureas appear to increase the risk, a new observational study in patients with type 2 diabetes suggests. The data, obtained from nationwide electronic medical from the US Veterans Affairs Administration, yielded a 22% lower risk of dementia with TZD monotherapy and a 12% … Read more